Overview

TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
To demonstrate efficacy and safety of TachoSil® in cardiovascular surgery
Phase:
Phase 4
Details
Lead Sponsor:
Nycomed
Treatments:
Hemostatics
Thrombin